大容量单体风电塔筒
Search documents
盘前公告淘金:奕帆传动拟购北京和利时87%股权,预计构成重大资产重组,同花顺净利预增50%-80%
Jin Rong Jie· 2026-01-21 01:27
【重要事项】 纳指科技ETF:将于1月21日开市起至当日10:30停牌 国投白银LOF:二级市场交易价格波动较大,1月21日开市起至当日10:30停牌 凯龙高科:筹划购买金旺达控制权21日起停牌,后者主要产品包括精密行星滚柱丝杆等 【资本运作】 震裕科技:2025年第四季度来自机器人行业订单有较明显增长 百利天恒:iza-bren用于治疗复发性或转移性食管鳞癌的上市申请获受理并被纳入优先审评品种名单, 为全球首个EGFR×HER3双抗ADC上市申请获受理 上海医药:B023细胞注射液获得临床试验批准通知书 全球未有同品种同适应症的药品上市 奕帆传动:拟购买北京和利时87.07%股权,预计构成重大资产重组 康欣新材:拟3.92亿元收购宇邦半导体51%股权,实现向半导体产业的战略转型与升级 明德生物:拟共同投资设立私募基金,投向光互联、半导体等人工智能基础设施/终端产业链 中钨高新:柿竹园公司增储9.17万吨钨金属量等资源 恒瑞医药:HRS-2141片获准开展2型糖尿病适应症的临床试验 【业绩】 海康威视:2025年净利润141.88亿元,同比增长18% 建投能源:2025年净利同比预增253.38% 通富微电: ...
1月20日晚间公告 | 利欧股份核查完成复牌;璞泰来等多家公司年报业绩大增
Xuan Gu Bao· 2026-01-20 12:10
Suspension and Resumption - Liao Co., Ltd. has completed the verification and resumed trading [1] - Kailong High-Tech is planning to acquire control of Jinwangda, resulting in stock suspension [2] External Investment and Daily Operations - Baili Tianheng's application for the marketing of iza-bren for the treatment of recurrent or metastatic esophageal squamous cell carcinoma has been accepted and included in the priority review list, marking the first global application for an EGFR×HER3 dual antibody ADC [3] - Huadian Technology has signed a contract worth 374 million yuan for the first phase of a 1 million kilowatt wind-solar hydrogen production project in Inner Mongolia [4] - Jinma Amusement plans to raise no more than 1.05 billion yuan through a private placement for projects related to cultural tourism robots, IP empowerment, and park construction and operation [4] - Zhenyu Technology anticipates a significant increase in orders from the robotics sector by Q4 2025, particularly for dexterous hand components and assemblies [4] Performance Changes - Putailai expects a net profit of 2.3 billion to 2.4 billion yuan in 2025, representing a year-on-year growth of 93.18% to 101.58%, driven by significant increases in wet diaphragm and coating processing business volumes [5] - Hikvision anticipates a net profit of 14.188 billion yuan in 2025, an 18% increase year-on-year [6] - Chipbond expects a net profit of 275 million to 295 million yuan in 2025, reflecting a growth of 71.13% to 83.58% due to breakthroughs in high-end PCB and semiconductor fields [6] - Allwinner Technology forecasts a net profit of 251 million to 295 million yuan in 2025, a growth of 50.53% to 76.92% driven by increased market demand and new product launches [6] - Yanjing Beer projects a net profit of 1.58352 billion to 1.74187 billion yuan in 2025, a growth of 50% to 65% year-on-year [7] - Zhongshi Technology expects a net profit of 330 million to 370 million yuan in 2025, a growth of 63.86% to 83.73% due to increased shipments of thermal materials and components [7] - Yutong Optical anticipates a net profit of 240 million to 280 million yuan in 2025, a growth of 30.75% to 52.54% driven by increased business volume in various optical components [7] - Tonghuashun expects a net profit of 2.735 billion to 3.282 billion yuan in 2025, reflecting a growth of 50% to 80% due to increased activity in the domestic capital market [7] - Tongfu Microelectronics projects a net profit of 1.1 billion to 1.35 billion yuan in 2025, a growth of 62.34% to 99.24% driven by structural growth in the global semiconductor industry [8] - Northeast Securities anticipates a net profit of 1.477 billion yuan in 2025, a growth of 69.06% due to increased investment and wealth management income [8]